Clinical Trial Update: Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG [Phase 2]

View source ↗

Summary

Phase 2 trial update for fixed-dose combinations of trabodenoson and latanoprost in adults with ocular hypertension or primary open-angle glaucoma; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Trabodenoson (trabodenoson)

Snippet

Sponsor: Inotek Pharmaceuticals Corporation | Conditions: Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 2 | Status: COMPLETED | Results posted: 2018-02-15